TY - JOUR
T1 - The impacts of deep surgical site infections on readmissions, length of stay, and costs
T2 - A matched case–control study conducted in an academic hospital in the netherlands
AU - Purba, Abdul Khairul Rizki
AU - Luz, Christian F.
AU - Wulandari, Riyanti R.
AU - van der Gun, Ieneke
AU - Dik, Jan Willem
AU - Friedrich, Alex W.
AU - Postma, Maarten J.
N1 - Funding Information:
W e would like to thank Igor van der W eide for providing the clinical data and reimbursement codes for this study . W e also thank Josue Almansa Ortiz for verifying the statistical results. This study was supported by the Groningen University Institute for Drug Exploration (GUIDE) of the Graduate School of Medical Sciences at the University Medical Center Groningen (UMCG) in the Netherlands. The study also received support from the Directorate General of Higher Education (DIKTI), the Ministry of Education and Culture of the Republic of Indonesia [No. 224/D3.2/PG/2016] and the Faculty of Medicine at Universitas Airlangga [No. 305/ UN3.5/SDM/2016]. In addition, CL was supported by the European Commission Horizon 2020 Framework Marie Skłodowska-Curie Actions (grant agreement number: 713660-PRONKJEW AIL-H2020-MSCA-COFUND-2015).
Publisher Copyright:
© 2020 Purba et al.
PY - 2020
Y1 - 2020
N2 - Objective: This study aimed to evaluate the impacts of deep surgical site infections (dSSIs) regarding hospital readmissions, prolonged length of stay (LoS), and estimated costs. Patients and Methods: We designed and applied a matched case–control observational study using the electronic health records at the University Medical Center Groningen in the Netherlands. We compared patients with dSSI and non-SSI, matched on the basis of having similar procedures. A prevailing topology of surgeries categorized as clean, clean-contami-nated, contaminated, and dirty was applied. Results: Out of a total of 12,285 patients, 393 dSSI were identified as cases, and 2864 patients without SSIs were selected as controls. A total of 343 dSSI patients (87%) and 2307 (81%) controls required hospital readmissions. The median LoS was 7 days (P25-P75: 2.5–14.5) for dSSI patients and 5 days (P25-P75: 1–9) for controls (p-value: <0.001). The estimated mean cost per hospital admission was €9,016 (SE±343) for dSSI patients and €5,409 (SE±120) for controls (p<0.001). Independent variables associated with dSSI were patient’s age ≥65 years (OR: 1.334; 95% CI: 1.036–1.720), the use of prophylactic antibiotics (OR: 0.424; 95% CI: 0.344–0.537), and neoplasms (OR: 2.050; 95% CI: 1.473–2.854). Conclusion: dSSI is associated with increased costs, prolonged LoS, and increased read-mission rates. Elevated risks were seen for elderly patients and those with neoplasms. Additionally, a protective effect of prophylactic antibiotics was found.
AB - Objective: This study aimed to evaluate the impacts of deep surgical site infections (dSSIs) regarding hospital readmissions, prolonged length of stay (LoS), and estimated costs. Patients and Methods: We designed and applied a matched case–control observational study using the electronic health records at the University Medical Center Groningen in the Netherlands. We compared patients with dSSI and non-SSI, matched on the basis of having similar procedures. A prevailing topology of surgeries categorized as clean, clean-contami-nated, contaminated, and dirty was applied. Results: Out of a total of 12,285 patients, 393 dSSI were identified as cases, and 2864 patients without SSIs were selected as controls. A total of 343 dSSI patients (87%) and 2307 (81%) controls required hospital readmissions. The median LoS was 7 days (P25-P75: 2.5–14.5) for dSSI patients and 5 days (P25-P75: 1–9) for controls (p-value: <0.001). The estimated mean cost per hospital admission was €9,016 (SE±343) for dSSI patients and €5,409 (SE±120) for controls (p<0.001). Independent variables associated with dSSI were patient’s age ≥65 years (OR: 1.334; 95% CI: 1.036–1.720), the use of prophylactic antibiotics (OR: 0.424; 95% CI: 0.344–0.537), and neoplasms (OR: 2.050; 95% CI: 1.473–2.854). Conclusion: dSSI is associated with increased costs, prolonged LoS, and increased read-mission rates. Elevated risks were seen for elderly patients and those with neoplasms. Additionally, a protective effect of prophylactic antibiotics was found.
KW - Cost
KW - Economic evaluation
KW - Patient admission
KW - Prophylactic antibiotic
KW - Surgical wound infection
UR - http://www.scopus.com/inward/record.url?scp=85092032628&partnerID=8YFLogxK
U2 - 10.2147/IDR.S264068
DO - 10.2147/IDR.S264068
M3 - Article
AN - SCOPUS:85092032628
SN - 1178-6973
VL - 13
SP - 3365
EP - 3374
JO - Infection and Drug Resistance
JF - Infection and Drug Resistance
ER -